Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype

Environmental Health Perspectives

Volumn 117, Issue 12, 2009, Pages 1847-1852

  Benbrahim Tallaa, Lamia ^a,c   Tokar, Erik J ^a   Diwan, Bhalchandra A ^b   Dill, Anna L ^a   Coppin, Jean François ^a   Waalkes, Michael P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b SAIC FREDERICK INC   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Basal type; Breast cancer; Cadmium; Estrogen receptor; Malignant transformation

Indexed keywords

BRCA1 PROTEIN; CADMIUM; CELL MARKER; CYTOKERATIN 5; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GELATINASE B; PROTEIN P63;

ANAPLASTIC CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST CELL; BREAST EPITHELIUM; CANCER CELL; CELL INVASION; CONTROLLED STUDY; DNA METHYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INOCULATION; LONG TERM EXPOSURE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE C MYC; ONCOGENE K RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; XENOGRAFT;

ANIMALS; AROMATASE; BREAST NEOPLASMS; CADMIUM; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; KERATIN-5; MEMBRANE PROTEINS; MICE; PHENOTYPE;

MUS;

EID: 75349113516     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0900999     Document Type: Article

References (43)

1. Agrawal A, Murphy RF, Agrawal DK. 2007. DNA methylation in breast and colorectal cancers. Mod Pathol 20:711-721.
2. Akesson A, Julin B, Wolk A. 2008. Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: a population-based prospective cohort study. Cancer Res 68:6435-6441.
3. Antila E, Mussalo-Rauhamaa H, Kantola M, Atroshi F, Westermarck T. 1996. Association of cadmium with human breast cancer. Sci Total Environ 186:251-256.
4. Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP. 2005. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol Appl Pharmacol 206:288-298.
5. Bernstein L. 2002. Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7:3-15.
6. Boecker W, Buerger H. 2003. Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept. Cell Prolif 36(suppl 1):73-84.
7. Bray F, McCarron P, Parkin DM. 2004. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6:229-239.
8. Cherian MG, Jayasurya A, Bay BH. 2003. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 533:201-209.
9. Chrestensen CA, Shuman JK, Eschenroeder A, Worthington M, Gram H, Sturgill TW. 2007. MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines. J Biol Chem 282:4243-4252.
10. Coyle YM. 2004. The effect of environment on breast cancer risk. Breast Cancer Res Treat 84:273-288.
11. Darbre PD. 2006. Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast. J Appl Toxicol 26:191-197.
12. Dontu G, Liu S, Wicha MS. 2005. Stem cells in mammary develop ment and carcinogenesis: implications for prevention and treatment. Stem Cell Rev 1:207-213.
13. Eckert LB, Repasky GA, Ulkü AS, McFall A, Zhou H, Sartor CI, et al. 2004. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res 64:4585-4592.
14. El Sharkawy SL, Farrag AR. 2008. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status. Appl Immunohistochem Mol Morphol16:108-112.
15. Fadare O, Tavassoli FA. 2007. The phenotypic spectrum of basal-like breast cancers: a critical appraisal. Adv Anat Pathol 14:358-373.
16. Garcia-Morales P, Saceda M, Kenney N, Kim N, Salomon DS, Gottardis MM, et al. 1994. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem 269:16896-16901.
17. Guével RL, Petit FG, Goff PL, Métivier R, Valotaire Y, Pakdel F. 2000. Inhibition of rainbow trout (Oncorhynchus mykiss) estrogen receptor activity by cadmium. Biol Reprod 63:259-266.
18. IARC (International Agency for Research on Cancer). 1993. Cadmium and cadmium compounds. IARC Monogr Eval Carcinog Risk Hum 58:119-237.
19. Institute of Laboratory Animal Resources. 1996. Guide for the Care and Use of Laboratory Animals. Washington, DC:National Academy Press.
20. Ionescu JG, Novotny J, Stejskal V, Lätsch A, Blaurock-Busch E, Eisenmann-Klein M. 2006. Increased levels of transition metals in breast cancer tissue. Neuro Endocrinol Lett 27(suppl 1):36-39.
21. Jamerson MH, Johnson MD, Dickson RB. 2004. Of mice and Myc: c-Myc and mammary tumorigenesis. J Mammary Gland Biol Neoplasia 9:27-37.
22. Jin R, Huang J, Tan PH, Bay BH. 2004. Clinicopathological significance of metallothioneins in breast cancer. Pathol Oncol Res 10:74-79.
23. Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, et al. 2003. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 9:1081-1084.
24. Li Q, Ahmed S, Loeb JA. 2004. Development of an autocrine neuregulin signaling loop with malignant transformation of human breast epithelial cells. Cancer Res 64:7078-7085.
25. Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD, et al. 2008. BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci USA 105:1680-1685.
26. McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, Newcomb PA. 2006. Cadmium exposure and breast cancer risk. J Natl Cancer Inst 98:869-873.
27. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
28. Qu W, Diwan BA, Reece JM, Bortner CD, Pi J, Liu J, et al. 2005. Cadmium-induced malignant transformation in rat liver cells: role of aberrant oncogene expression and minimal role of oxidative stress. Int J Cancer 114:346-355.
29. Ribeiro-Silva A, Ramalho LN, Garcia SB, Brandão DF, Chahud F, Zucoloto S. 2005. p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer. Histopathology 47:458-466.
30. Rydzewska A, Król I, Lipińnski L. 2004. Concentration of cadmium in breast cancer tissue of women living in the Wielkopoiska region [in Polish]. Przegl Lek 61:786-788.
31. Shekhar PV, Chen ML, Werdell J, Heppner GH, Miller FR, Christman JK. 1998. Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: a model for early breast cancer. Int J Oncol 13:907-915.
32. Silva E, Lopez-Espinosa MJ, Molina-Molina JM, Fernández M, Olea N, Kortenkamp A. 2006. Lack of activity of cadmium in in vitro estrogenicity assays. Toxicol Appl Pharmacol 216:20-28.
33. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, et al. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086.
34. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, et al. 2006. Purification and unique properties of mammary epithelial stem cells. Nature 439:993-997.
35. Stoica A, Katzenellenbogen BS, Martin MB. 2000. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 14:545-553.
36. Strumylaite L, Bogusevicius A, Ryselis S, Pranys D, Poskiene L, Kregzdyte R, et al. 2008. Association between cadmium and breast cancer [in Lithuanian]. Medicina (Kaunas) 44:415-420.
37. Takiguchi M, Achanzar WE, Qu W, Li G, Waalkes MP. 2003. Effects of cadmium on DNA-(cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp Cell Res 286:355-365.
38. Tokar EJ, Webber MM. 2005. Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells. Clin Exp Metastasis 22:275-284.
39. Waalkes MP. 2003. Cadmium carcinogenesis. Mutat Res 533:107-120.
40. Wicha MS, Liu S, Dontu G. 2006. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66:1883-1890.
41. Yehiely F, Moyano JV, Evans JR, Nielsen TO, Cryns VL. 2006. Deconstructing the molecular portrait of basal-like breast cancer. Trends Mol Med 12:537-544.
42. You F, Chiba N, Ishioka C, Parvin JD. 2004. Expression of an amino-terminal BRCA1 deletion mutant causes a dominant growth inhibition in MCF10A cells. Oncogene 23:5792-5798.
43. Zhang X, Shen P, Coleman M, Zou W, Loggie BW, Smith LM, et al. 2005. Caveolin-1 down-regulation activates estrogen receptor alpha expression and leads to 17beta-estradiol-stimulated mammary tumorigenesis. Anticancer Res 25:369-375.